Filing Flows

Filing Flows › GeoVax Labs (GOVX) › Q2 2025 › vs Q1 2025

GeoVax Labs (GOVX) Q2 2025 vs Q1 2025 (quarter over quarter)

GeoVax Labs's revenue fell $785K (-48%) from $1.6M in Q1 2025 to $852K in Q2 2025.

GeoVax Labs, Q2 2025: revenue $852K (+184% year over year), operating margin -635.8%, net loss $5.4M, operating cash flow −$4.3M. The chart draws each line against Q1 2025, the increases inside each band.

GeoVax Labs: what changed, Q2 2025 vs Q1 2025GeoVax Labs: what changed, Q2 2025 vs Q1 2025Working capital & other$1.6MCash used in operations−$1.6MCosts & expenses−$771KOperating costs−$771KResearch & development−$626KGeneral & admin−$145KNet loss$12KOperating cash sources$12KNet loss absorbed$12KOther income, net$2K

Every line

LineQ2 2025Q1 2025Change%
Revenue$852K$1.6M−$785K-48%
Other income, net$49K$48K$2K+3%
Net loss$5.4M$5.4M$12K+0.2%
Costs & expenses$6.3M$7.0M−$771K-11%
Operating costs$6.3M$7.0M−$771K-11%
Research & development$4.7M$5.4M−$626K-12%
General & admin$1.5M$1.7M−$145K-9%
Operating cash sources$5.4M$5.4M$12K+0.2%
Depreciation & amortization$17K$17K−$118-0.7%
Share-based compensation$293K$293K−$40%
Working capital & other$726K−$918K$1.6M—
Cash used in operations$4.3M$6.0M−$1.6M-27%
Net loss absorbed$5.4M$5.4M$12K+0.2%

Questions

How much did GeoVax Labs's revenue grow quarter over quarter in Q2 2025?

GeoVax Labs's revenue fell $785K (-48%) from $1.6M in Q1 2025 to $852K in Q2 2025.

Q2 2025 results → · Compare in the interactive Sankey →